Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Phase II trial explores topical AVR-118 as wound healing agent

Jan. 31, 2007

Yaz approved to treat acne in women

Jan. 31, 2007

New therapeutic agents for skin disorders disclosed in recent Pfizer and Ligand patents

Jan. 29, 2007

U.K. clearance for phase III trials of CUV-1647 in polymorphous light eruption

Jan. 25, 2007

CLS-001 begins phase II study in rosacea

Jan. 24, 2007

New phase II study for PEP-005 Topical in actinic keratosis

Jan. 23, 2007

Hivenyl significantly reduces atopic dermatitis itch severity without sedation

Jan. 22, 2007

Cipher's response to CIP-Isotretinoin approvable letter accepted for review

Jan. 19, 2007

Dermylex available in Canada for psoriasis

Jan. 17, 2007

Recent Merck KGaA patent describes new therapeutic agents for skin hyperpigmentation

Jan. 12, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...